➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Baxter
Express Scripts
Moodys
Boehringer Ingelheim

Last Updated: April 18, 2021

DrugPatentWatch Database Preview

VERMOX Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Vermox patents expire, and what generic alternatives are available?

Vermox is a drug marketed by Janssen Pharms and is included in two NDAs.

The generic ingredient in VERMOX is mebendazole. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the mebendazole profile page.

Summary for VERMOX
US Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: 2
Bulk Api Vendors: 124
Clinical Trials: 6
Patent Applications: 3,372
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in VERMOX?VERMOX excipients list
DailyMed Link:VERMOX at DailyMed
Drug patent expirations by year for VERMOX
Recent Clinical Trials for VERMOX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
RDD Pharma LtdPhase 2
Noguchi Memorial Institute for Medical ResearchPhase 4
HopeXchange Medical Center, GhanaPhase 4

See all VERMOX clinical trials

Pharmacology for VERMOX
Drug ClassAnthelmintic

US Patents and Regulatory Information for VERMOX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms VERMOX mebendazole TABLET, CHEWABLE;ORAL 017481-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Janssen Pharms VERMOX mebendazole TABLET, CHEWABLE;ORAL 208398-001 Oct 19, 2016 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Dow
Baxter
Johnson and Johnson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.